A total of 113 patients with inoperable malignant biliary strictures were analyzed retrospectively. Metallic stents (MS ; 81 patients), single Tannenbaum stents (STS ; 9 patients) and double Tannenbaum stents (DTS ; 23 patients) were placed consecutively in our institute between 1995 and 2003. The stent patency period, survival period, effect of chemotherapy on survival, occlusion ratio, and complications were compared among the MS, STS and DTS groups. Significant differences were found in the 50% patency period among the three groups (MS; 172 days, STS; 91 days, DTS; 235 days, Kaplan-Meier method, log-rank test, p<0.05), although when pancreatic cancer patients alone were considered for the analysis, no differences in the patency period were noted (MS; 234 days, DTS; 235 days, p<0.05). The survival period was significantly prolonged with chemotherapy in the DTS group (median survival period; with chemotherapy 375 days, without chemotherapy 103 days), while no survival benefit was obtained in the MS group. The occlusion ratio was significantly higher in the STS group (67%) as compared with that in the MS group (38%) and DTS group (14%). Univariate analysis was performed by the Kaplan-Meier method compared by the log-rank test to determine the risk factors for stent occlusion. Then, variables with a P value of less than 0.05 determined from the univariate analysis were introduced into the Cox proportional hazards model, and the odds ratios, 95% confidence intervals and P-values were calculated. The results revealed STS and gender to be statistically significant risk factors for stent occlusion. The DTS group not only showed a significantly prolonged patency period, but also good survival benefit with chemotherapy for pancreatic cancer as compared with the results in the MS group. Bile drainage through the gap between the two plastic stents (interductal drainage) may have played a key role in the notably improved drainage effect of the plastic stent. DTS could well be a good option for biliary strictures caused by pancreatic cancer.
View full abstract